Clinical CYP2D6-Mediated Pharmacokinetic Drug-Drug Interactions of DA-8010 with Paroxetine or Mirabegron in Healthy Korean Participants. [PDF]
Ryu H, Cho JY, Lee DY, Lee S.
europepmc +1 more source
Impact of CYP2D6 Metabolizer Status on Ondansetron Efficacy in Early Pregnancy Induced Nausea and Vomiting: A Case Control Study. [PDF]
Liu M +14 more
europepmc +1 more source
Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans. [PDF]
Aurinsalo L +7 more
europepmc +1 more source
PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy. [PDF]
Seok J, Kang N, Lee JJ, Cho CK, Lee YJ.
europepmc +1 more source
Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort. [PDF]
Dixon P +4 more
europepmc +1 more source
Profound Synergistic Bradycardia: Pharmacokinetic Consequences of Paxlovid-Mediated CYP3A4 and CYP2D6 Inhibition on Ranolazine, Diltiazem, and Metoprolol. [PDF]
Bactawar SB, Gaibor C, Abdul-Waheed M.
europepmc +1 more source
Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6-Mediated Drug-Drug-Gene Interactions of Venlafaxine in Koreans. [PDF]
Bae S +8 more
europepmc +1 more source
Dietary-Driven Gene Expansion. [PDF]
Ingelman-Sundberg M.
europepmc +1 more source
Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors. [PDF]
Riad MMH, Marroum P, Shebley M, Xiong H.
europepmc +1 more source
Pharmacogenomic Insights: The Role of CYP2D6 Allelic Variants in Drug Metabolism Among COVID-19 Patients With Comorbidities. [PDF]
Özen M +7 more
europepmc +1 more source

